Over the last 8 years, a 5-fold increase in the incidence of mice with spontaneous hepatoblastomas and a moderate increase in the incidence of chemically induced hepatoblastomas in B6C3F1 mice occurred in 2-year NTP studies compared to the previous 7 years. There was a positive association between an increased incidence of mice with hepatoblastoma and an increased incidence of mice with hepatocellular tumors in the treated mice. The rate of pulmonary metastases for hepatoblastoma was similar to that of pulmonary metastasis for hepatocellular carcinomas. Although a variety of chemicals caused an increased incidence of mice with hepatoblastoma, there was no apparent association between a specificchemical structure or a biological class of compounds and their capacity to induce hepatoblastomas. Hepatoblastomas frequently arose within hepatocellular carcinomas or adenoma s and were induced by the same compound s that induced hepatocellular neoplasms. Therefore, it seems reasonable to combine the incidence of mice with hepatoblastomas and the incidence of mice with hepatocellular carcinomas in hazard identification studies.
Anna CH, Sills RC, Foley JF, Stockton PS, Ton T-V., Devereux TR (2000). β-Catenin mutations and protein accumulation in all hepatoblastoma s examined from mice treated with anthraquinone or oxazepam . Cancer Res60: 2864—2868.
2.
Beiler GS, Williams RL (1993). Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics49: 793— 801.
3.
Boorman GA, Eustis SL (1986). The pathology working group as a means for assuring pathology quality in toxicological studies In: Managing Conduct and Data Quality of Toxicological Studies, Hoover BK, Baldwin JK, Uelner AF, Whitmire CE, Davies CL, Bristol DW (eds). Princeton Scientific Publishing Co, Princeton, New Jersey, pp 271—275.
4.
Bucher JR, Shackelford CC, Haseman JK, Johnson JD, Kurtz PJ, Persing RL (1994). Carcinogenicity studies of oxazepam in mice. Fundam Appl Toxicol23: 280—297.
5.
Buckley JD, Sather H., Riccione K., Rogers PC, Haas JE, Henderson BE, Hammond GD (1989). A case-control study of risk factors for hepatoblastoma. A report from the children's cancer study group. Cancer64: 1169— 1176.
6.
Carceller A. , Blanchard H., Champangne J., St-Vil D., Bensoussan AL (2001). Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma. J Pediatr Surg36: 755—759.
7.
Chhabra RS, Eustis SL, Haseman JK, Kurtz PJ, Carlton WW (1992). Comparative carcinogenicity of ethylene thiourea with or without perinatal exposure in rats and mice. Fundam Appl Toxicol18: 405—417.
8.
Diwan BA, Ward JW, Kurata Y., Rice JM ( 1994). Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitrosodiethylamine and subsequently given aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarbitol. Toxicol Pathol22: 430— 439.
9.
Diwan BA, Ward JW, Ramljak D., Anderson LM (1997). Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice. Toxicol Path25: 597— 605.
10.
Diwan BA, Ward JW, Rice JM ( 1989). Promotion of malignant `embryonal' liver tumors by phenobarbital: Increased incidence and shortened latency of hepatoblastomas in (DBS/2 x C57BL/6) F1 mice initiated by N-nitrosodiethylamine. Carcinogenesis10: 1345—1348.
11.
Feusner J., Buckley JD, Robison L., Ross JA, Van Tornout J. (1998). Pre-maturity and hepatoblastoma: More than just an association. J Pediatr133: 585—586.
12.
Frith CH, Ward JW, Turusov VS (1994). Tumours of the liver. In Pathology of Tumours in Laboratory Animals. Volume 2—Tumours of the Mouse, Turusov VS, Mohr U (eds). IARC Scientific Publications, Lyon , pp 223—269.
13.
Gaylor DW, Kodell RL (2001). Dose-respons e trend tests for tumorigenesi s adjusted for differences in survival and body weight across doses. Toxicol Sci59: 219—225.
14.
Hailey JR, Haseman J., Bucher JR, Radovsky AE, Malarkey DE, Miller RT, Nyska A., Maronpot RR (1998). Impact of Helicobacter hepaticus in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Toxicol Pathol26: 602—611.
15.
Harada T., Enomoto A., Boorman GA, Maronpot RR (1999). Liver and gall-bladder. In Pathology of the Mouse, Maronpot RR, Boorman GA, Gaul BW (eds). Cache River Press, Vienna, Illinois , pp 119—184.
16.
Haseman JK, Hailey JR, Morris RW (1998). Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: A National Toxicology Program update. Toxicol Pathol26: 428— 441.
17.
Haseman JK, Huff JE, Rao GN, Arnold JE, Boorman GA, McConnell EE (1985). Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N x C3H/HeN) F1 (B6C3F1) mice. J Natl Cancer Inst75: 975—984.
18.
Haseman JK, Young E., Eustis SL, Hailey JR (1997). Body weight-tumor correlations in long-term rodent carcinogenicity studies. Toxicol Pathol25: 256—263.
19.
Ishak KG, Glunz PR (1967). Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer20: 396—422.
20.
Johnson JD, Ryan MJ, Tuft JD, Graves SW, Hejmancik MR, Cunningham ML, Herbert R., Abdo KM ( 2000). Two-year toxicity and carcinogenicity study of methyleugenol in F344/N rats and B6C3F12 mice. J Agric Food Chem48: 3620—3632.
21.
Kharkovskaya NA, Svinolupova SI, Khrustalev SA, Engelhardt NV, Kondalenko VF, Poltoranina VS, Turusov VS (1990). Transplantable mouse hepatoblastoma: Histologic, ultrastructural and immunohistochemical study . Exp Pathol40: 283—289.
22.
Koch A., Denkhaus D., Albrecht S., Leuschner I., von Schweinitz D., Pietsch T. (1999). Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res59: 269—273.
23.
Lack EE, Neave C., Vawter GF (1982). Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol6: 693—705.
24.
Maronpot RR , Haseman JK, Boorman GA, Eustis SL, Rao GN, Huff JE (1987). Liver lesions in B6C3F1 mice: The National Toxicology Program, experience and position. Arch Toxicol Suppl10: 10—26.
25.
National Toxicology Program (NTP) (1992). Toxicology and carcinogenesi s studies of ethylene thiourea (CAS NO. 96-45-7) inF344/N rats and B6C3F1 mice (feed study) In: NTP Technical Report No. 388. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina.
26.
National Research Council (NRC) (1996). Guide for the Care and Use of Laboratory Animals , 7th ed, ILAR, Vol.1. National Academy Press, Washington, DC, p 125.
27.
National Toxicology Program (NTP) (1993). Toxicology and carcinogenesi s studies of o-nitroanisole (CAS NO. 91-23-6) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 416. US Department of Health and Human Services, Public Health Service, National Institutes of Health , Research Triangle Park, North Carolina, pp 1—473.
28.
National Toxicology Program (NTP) (1993). Toxicology and carcinogenesi s studies of oxazepam (CAS NO. 604-75-1) in Swiss-Webster B6C3F1 mice (feed studies). In: NTP Technical Report No. 443. US Department of Health and Human Services, Public Health Service, National Institutes of Health , Research Triangle Park, North Carolina, pp 1—316.
29.
National Toxicology Program (NTP) (1995). Toxicology and carcinogenesi s studies of methyphenidate hydrochloride (CAS NO. 298-59-9) in F344/N rats and B6C3F1 mice (feed studies) . In: NTP Technical Report No. 439. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—294.
30.
National Toxicology Program (NTP) (1996). Toxicology and carcinogenesis studies of 1-amino-2,4-dibromoanthraquinon e (CAS NO. 81-49-2) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 383. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—370.
31.
National Toxicology Program (NTP) (1999). Toxicology and carcinogenesi s studies of anthraquinone (CAS NO. 86-65-1) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 494. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—325.
32.
National Toxicology Program (NTP) (1999). Toxicology and carcinogenesi s studies of diethanolamine (CAS NO. 111-42-2) in F344/N rats and B6C3F1 mice (dermal studies). In: NTP Technical Report No. 478. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—211.
33.
National Toxicology Program (NTP) (2000). Toxicology and carcinogenesis studies of methyleugenol (CAS NO. 93-15-2) in F344/N rats and B6C3F1 mice (gavage studies). In: NTP Technical Report No. 491. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—412.
34.
National Toxicology Program (NTP) (2000). Toxicology and carcinogenesi s studies of primidone (CAS NO. 125-33-7) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 476. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—290.
35.
National Toxicology Program (NTP) (2000). Toxicology and carcinogenesi s studies of pyridine (CAS NO. 110-86-1) in F344/N rats and B6C3F1 mice (drinking water studies). In: NTP Technical Report No. 470. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—327.
36.
National Toxicology Program (NTP) (2001). Toxicology and carcinogenesi s studies of coconut oil acid diethanolamine condensate (CAS NO. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies) . In: NTP Technical Report No. 479. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research TrianglePark, North Carolina, pp 1—226.
37.
Nonoyama T. , Reznik G., Bucci TJ, Fullerton F. (1986). Hepatoblastoma with squamous differentiation in a B6C3F1 mouse. Vet Pathol23: 619—622.
38.
Nyska A., Maronpot RR, Eldridge SR, Haseman JK, Hailey JR (1997). Alteration in cell kinetics in control B6C3F1 mice infected with Helicobacter hepaticus. Toxicol Path25: 591—596.
39.
Rao GN (1996). New diet (NTP 2000) for rats in the National Toxicology Program's toxicology and carcinogenesi s studies. Fundam Appl Toxicol31: 102—108.
40.
Rao GN (1997). New nonpurifieddiet (NTP 2000) for rodents in the National Toxicology Program's toxicology and carcinogenesi s studies. J Nutr127: 842S—846S.
41.
Rao GN (1999). Growth, body weight patterns, and life span of the B6C3F1 mouse. In: Pathology of the Mouse, Maronpot RR, Boorman GA, Gaul BW (eds). Cache River Press, Vienna, Illinois, pp 7—12.
42.
Reik W., Romer I., Barton SC, Surani MA, Howlett SK, Klose J. (1993). Adult phenotype in the mouse can be affected by epigenetic events in the early embryo. Development119: 933—942.
43.
Ross JA, Gurney JG (1998). Hepatoblastoma incidence in the United States from 1973 to 1992. Med Pediatr Oncol30: 141—142.
44.
Sattler B., Gunawan B., Lorf T., Muller D., Ringe B., Fuzesi L. (2000). Undifferentiated small-cell hepatoblastoma. Pathologe21: 456—459.
45.
Snedecor GW, Cochran WG (1980). Statistical Methods, Vol. 1, 1980. Iowa State University Press, Ames, Iowa, pp 1—288.
46.
Tanimura M. , Matsui I., Abe J., Ikeda H., Kobayashi N., Ohira M., Yokoyama M., Kaneko M. (1998). Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res58: 3032—3035.
47.
Turusov VS, Deringer MK, Dunn TB, Stewart HL (1973). Malignant liver tumor in mice resembling human hepatoblastoma. J Natl Cancer Inst51: 1689—1695.
48.
Van Tornout J., Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA (1997). Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: A report from the Children's Cancer Group. J Clin Oncol15: 1190—1197.
49.
Warfel KA, Hull MT ( 1992). Hepatoblastomas—An ultrastructural and immunohistochemica l study. Ultrastr Path16: 451—461.
50.
Whitmore SP , Gilliam AF, Hendren RW, Lewis SE, Rao GN, Whisnant CC (1996). Genetic monitoring of inbred rodents from controlled production colonies through biochemical markers and skin grafting procedures. Lab An Sci46: 585—588.
